Fount of Information

TriLink BioTechnologies社 December TriLink Messenger



TriLink_Dec2.jpg TriLink_Dec3.jpg

Advances in mRNA nanotherapy

A new Nano Today review reports key milestones in mRNA nanotherapy, including the development of TriLink’s CleanCap® technology, which was used to cap the Pfizer/BioNTech COVID-19 vaccine. Learn how TriLink’s CleanCap® technology is advancing the development of mRNA nanotherapies.

Read more 

A long-read sequencing method for assessing mRNA...

Find out how University of Queensland researchers used TriLink’s CleanCap® mRNA Capping technology and N1-Methylpseudouridine-5'-Triphosphate to develop VAX-seq, a streamlined alternative to current industry standard methods for assessing mRNA vaccine quality.

Read more

Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。